{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:35:07Z","timestamp":1697441707809},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/olq.0000000000000061","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T02:59:57Z","timestamp":1385434797000},"page":"64-66","source":"Crossref","is-referenced-by-count":10,"title":["Use of First-Line Treatment for Neisseria gonorrhoeae After Treatment Guideline Changes"],"prefix":"10.1097","volume":"41","author":[{"given":"Greta","family":"Anschuetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenore","family":"Asbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210213","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jama.2013.2131","article-title":"CDC grand rounds: The growing threat of multidrug-resistant gonorrhea.","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"R2-14-20210213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection.","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-14-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010.","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"R4-14-20210213","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"R5-14-20210213","first-page":"590","article-title":"Update to CDCs sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"R8-14-20210213","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2011.300283","article-title":"Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.","volume":"102","author":"Dowell","year":"2011","journal-title":"Am J Public Health"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0000000000000061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:36:38Z","timestamp":1620966998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201401000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0000000000000061","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}